Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 29.

Modaressi, K; Niggli, F K; Fuchs, B (2012). Strategisches Vorgehen bei Verdacht auf Knochensarkom. Schweizer Zeitschrift für Onkologie, (2):12-17.

Fisch, U P; Zehnder, A; Hirt, A; Niggli, F K; Simon, A; Ozsahin, H; Schlapbach, L J; Ammann, R A (2011). Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer. Swiss Medical Weekly, 141:w13191.

Walter, D; Satheesha, S; Albrecht, P; Bornhauser, B C; D'Alessandro, V; Oesch, S M; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, F K; Schäfer, B W (2011). CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS ONE, 6(5):e19506.

Michel, G; Kuehni, C E; Rebholz, C E; Zimmermann, K; Eiser, C; Rueegg, C S; von der Weid, N X; Grotzer, M; Niggli, F K (2011). Can health beliefs help in explaining attendance to follow-up care? The Swiss childhood cancer survivor study. Psycho-Oncology, 20(10):1034-1043.

Rebholz, C E; von der Weid, N X; Michel, G; Niggli, F K; Kuehni, C E (2011). Follow-up care amongst long-term childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor Study. European Journal of Cancer, 47(2):229-221.

Burger, A; Koesters, R; Schäfer, B W; Niggli, F K (2011). Generation of a novel rtTA transgenic mouse to induce time-controlled, tissue-specific alterations in Pax2-expressing cells. Genesis: The Journal of Genetics and Development, 49(10):797-802.

Agyeman, P; Aebi, C; Hirt, A; Niggli, F K; Nadal, D; Simon, A; Ozsahin, H; Kontny, U; Kühne, T; Beck Popovic, M; Leibundgut, K; Bodmer, N; Ammann, R A (2011). Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. The Pediatric Infectious Disease Journal, 30(7):e114-e119.

Schmitz, M; Breithaupt, P; Scheidegger, N; Cario, G; Bonapace, L; Meissner, B; Mirkowska, P; Tchinda, J; Niggli, F K; Stanulla, M; Schrappe, M; Schrauder, A; Bornhauser, B C; Bourquin, J P (2011). Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood, 118(7):1854-1864.

Ammann, R A; Bodmer, N; Hirt, A; Niggli, F K; Nadal, D; Simon, A; Ozsahin, H; Kontny, U; Kühne, T; Beck Popovic, M; Ridolfi Lüthy, A; Aebi, C (2010). Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. Journal of Clinical Oncology, 28(12):2008-2014.

Hajdin, K; D'Alessandro, V; Niggli, F K; Schäfer, B W; Bernasconi, M (2010). Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model. PLoS ONE, 5(5):e10445.

Niggli, F K; Lamontage-Müller, I (2010). Goethe, Tucholsky und GCP. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer:214-215.

Bonapace, L; Bornhauser, B C; Schmitz, M; Cario, G; Ziegler, Urs; Niggli, F K; Schäfer, B W; Schrappe, M; Stanulla, M; Bourquin, J P (2010). Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. Journal of Clinical Investigation, 120(4):1310-1323.

Niggli, F K (2010). Renal tumors in Paediatric Nephrology. In: Leumann, E; Tsygin, A; Sarkissian, A. A Textbook for medical practitioners. Moscow: Littera Publishers, 215-219.

Hecker, R M; Amstutz, R A; Wachtel, M; Walter, D; Niggli, F K; Schäfer, B W (2010). p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment. Oncogene, 29(27):3942-3952.

Witt, H; Hajdin, K; Iljin, K; Greiner, O; Niggli, F K; Schäfer, B W; Bernasconi, M (2009). Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1. International Journal of Cancer, 124(9):2026-2032.

Grass, B; Wachtel, M; Behnke, S; Leuschner, I; Niggli, F K; Schäfer, B W (2009). Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics. Histopathology, 54(7):873-879.

Wehrli, L A; Braun, J; Buetti, L N; Hagleitner, N; Hengartner, H; Kühne, T; Lüer, S; Ozsahin, H; Beck Popovic, M; Niggli, F K; Betts, D R; Bourquin, J P (2009). Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics, 189(1):29-36.

Zehnder, A; Fisch, U; Hirt, A; Niggli, F K; Simon, A; Ozsahin, H; Schlapbach, L J; Ammann, R A (2009). Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatric Blood & Cancer, 53(1):53-57.

Flahaut, M; Meier, R; Coulon, A; Nardou, K A; Niggli, F K; Martinet, D; Beckmann, J S; Joseph, J-M; Mühlethaler-Mottet, A; Gross, N (2009). The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene, 28(23):2245-2256.

Amstutz, R; Wachtel, M; Troxler, H; Kleinert, P; Ebauer, M; Haneke, T; Oehler-Jänne, C; Fabbro, D; Niggli, F K; Schäfer, B W (2008). Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities. Cancer Research, 68(10):3767-3776.

Betts, D R; Stanchescu, R; Niggli, F K; Cohen, N; Rechavi, G; Amariglio, N; Trakhtenbrot, L (2008). SKY reveals a high frequency of unbalanced translocations involving chromosome 6 in t(12;21)-positive acute lymphoblastic leukemia. Leukemia Research, 32(1):39-43.

Haeberli, S; Grotzer, M A; Niggli, F K; Landolt, M A; Linsenmeier, C; Ammann, R A; Bodmer, N (2008). A psychoeducational intervention reduces the need for anesthesia during radiotherapy for young childhood cancer patients. Radiation Oncology, 3:17.

Traykova-Brauch, M; Schönig, K; Greiner, O; Miloud, T; Jauch, A; Bode, M; Felsher, D W; Glick, A B; Kwiatkowski, D J; Bujard, H; Horst, J; von Knebel Doeberitz, M; Niggli, F K; Kriz, W; Gröne, H J; Koesters, R (2008). An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice. Nature Medicine, 14(9):979-984.

Teuffel, O; Stanulla, M; Cario, G; Ludwig, W D; Rottgers, S; Schafer, B W; Zimmermann, M; Schrappe, M; Niggli, F K (2008). Anemia and survival in childhood acute lymphoblastic leukemia. Haematologica, 93(11):1652-7.

Wiegering, V A; Kellenberger, C J; Bodmer, N; Bergstraesser, E; Niggli, F K; Grotzer, M A; Nadal, D; Bourquin, J P (2008). Conservative management of acute appendicitis in children with hematologic malignancies during chemotherapy-induced neutropenia. Journal of Pediatric Hematology/Oncology, 30(6):464-467.

Muntean, A; Bergsträsser, E; Diepold, M; Niggli, F K; Betts, D R (2008). Karyotypic characterization of infant embryonal rhabdomyosarcoma. Cancer Genetics and Cytogenetics, 180(2):145-148.

Flohr, T; Schrauder, A; Cazzaniga, G; Panzer-Grümayer, R; van der Velden, V; Fischer, S; Stanulla, M; Basso, G; Niggli, F K; Schäfer, B W; Sutton, R; Koehler, R; Zimmermann, M; Valsecchi, M G; Gadner, H; Masera, G; Schrappe, M; van Dongen, J J M; Biondi, A; Bartram, C R (2008). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22(4):771-782.

Bernasconi, M; Berger, C; Sigrist, J A; Bonanomi, A; Sobek, J; Niggli, F K; Nadal, D (2006). Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virology Journal, 3:43.

Schmugge, M; Boltshauser, E; Plüss, H J; Niggli, F K (2000). Long-term follow-up and residual sequelae after treatment for intracerebral germ-cell tumour in children and adolescents. Annals of Oncology, 11(5):527-533.

This list was generated on Thu Sep 19 04:55:02 2019 CEST.